LifeMD, Inc. (NASDAQ: LFMD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
LifeMD First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
LifeMD, Inc. (NASDAQ: LFMD) had its price target raised by analysts at Cantor Fitzgerald from $13.00 to $15.00. They now have an "overweight" rating on the stock.
LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance